Dr. Ghaith Mansour | Pharmacology and Drug Development | Research Excellence Award

Published on by Life Science

Dr. Ghaith Mansour | Pharmacology and Drug Development | Research Excellence Award

Alfaisal University | Saudi Arabia

Ghaith Khalid Mansour is a dedicated PharmD student at Alfaisal University, Riyadh, recognized consistently on the Dean’s List for his academic excellence and strong commitment to advancing the field of pharmacy. His professional development spans meaningful volunteer experiences with leading organizations such as the Saudi Society of Clinical Pharmacy and several impactful health awareness events addressing medication misuse, antibiotic resistance, and dermatological conditions. He has contributed to high-level academic activities, including poster presentations at the 13th College of Pharmacy Research Day at King Saud University and the 15th Annual Research Day at Alfaisal University, earning the 3rd place Young Pharmacist Research Award. His research interest centers on innovative therapeutic strategies, including bioelectronic neuromodulation of renal nerves for hypertension treatment, alongside broader interests in clinical pharmacy, pharmacoeconomics, and public health. He has held leadership roles such as serving as a batch leader at the College of Pharmacy and working with the Saudi Pharmacoeconomic Expert Group on value-based healthcare strategies. Supported by numerous international certifications, he remains focused on contributing to innovative pharmacy practice, advancing patient care, and driving positive healthcare outcomes through research, service, and professional leadership.

Profile: Google Scholar 
Featured Publications

Ameer, O. Z., Mansour, G. K., Al-Amoudi, R. S., & Abu-Owaimer, F. M. (2025). Exploring dupilumab for asthma: From mechanistic insights to clinical outcomes, safety and cost-effectiveness. Frontiers in Pharmacology, 16, 1631321.

Mansour, G. K., Alangari, L, Khosyfan, L, Alhammad, R., & Hajjar, A. W. (2025). Efgartigimod for generalized myasthenia gravis and beyond: A narrative review of its pharmacological profile, clinical utility, and expanding applications. Biomedicines, 13(12), 2975.

Mansour, G. K., & AlGoraini, Y. (2025). Pediatric anaphylaxis in the emergency department: From mechanisms to personalized care. Cureus, 17(10).

Mansour, G. K., Yousif, A., & Mansour, G. (2025). Magnesium sulfate in pediatric emergency medicine: Pharmacology, evidence, and clinical applications. Cureus, 17(9).

Mansour, G. K., Hajjar, A. W., & Sajid, M. R. (2025). Therapeutic targeting of the hepcidin-ferroportin axis and erythropoietic modulators: A narrative review. Frontiers in Medicine, 12, 1726337.

Cheng Ji | Regenerative Medicine | Best Researcher Award

Published on by Life Science

Assoc. Prof. Dr. Cheng Ji | Regenerative Medicine | Best Researcher Award

Jiangsu University | China

Dr. Cheng Ji, an Associate Professor at Jiangsu University Medical College, has established a strong research foundation in the field of stem cell extracellular vesicles (EVs) and renal tissue regeneration. With an h-index of 23, he has authored 30 SCI-indexed publications that have collectively garnered over 1,200 citations, reflecting his impactful contributions to regenerative medicine and translational nanobiotechnology. His ongoing investigations center on the mechanistic roles of mesenchymal stem cell-derived EVs in mitigating acute and chronic kidney injury, focusing on fibrosis prevention through ubiquitination pathways. Dr. Ji has successfully completed two research projects and continues work on three ongoing studies, complemented by five industry collaborations that bridge academic discovery with clinical application. His book, Extracellular Vesicles: From Bench to Bedside, exemplifies his leadership in knowledge dissemination, while six patents highlight his commitment to innovation. As a member of the International Society for Extracellular Vesicles (ISEV), Dr. Ji actively contributes to global collaborative research networks. His integrative work on magnetically modified dual-targeted stem cell EVs to combat chronic kidney fibrosis positions him as a frontrunner for the Best Researcher Award, with a research vision that unites molecular insight and therapeutic advancement.

Featured Publications

Jin, C., Wu, P., Wu, W., Chen, W., Liu, W., Zhu, Y., Wu, Q., Chen, B., Ji, C., & Qian, H. Therapeutic role of hucMSC-sEV-enriched miR-13896 in cisplatin-induced acute kidney injury through M2 macrophage polarization. Cell Biology and Toxicology.

Wang, M., Yang, D., Li, L., Wu, P., Sun, Y., Zhang, X., Ji, C., Xu, W., Qian, H., & Shi, H.  A dual role of mesenchymal stem cell derived small extracellular vesicles on TRPC6 protein and mitochondria to promote diabetic wound healing. ACS Nano.

Ji, C., Zhang, J., Shi, L., Shi, H., Xu, W., Jin, J., & Qian, H. Engineered extracellular vesicle-encapsulated CHIP as novel nanotherapeutics for treatment of renal fibrosis. npj Regenerative Medicine.

Zhang, J., Gu, J., Wang, X., Ji, C., Yu, D., Wang, M., Pan, J., Santos, H. A., Zhang, H., & Zhang, X. Engineering and targeting neutrophils for cancer therapy. Advanced Materials.

Zhang, J., Yu, D., Ji, C., Wang, M., Fu, M., Qian, Y., Zhang, X., Ji, R., Li, C., & Gu, J. Exosomal miR-4745-5p/3911 from N2-polarized tumor-associated neutrophils promotes gastric cancer metastasis by regulating SLIT2. Molecular Cancer.